End-of-day quote
Shanghai S.E.
03:30:00 26/04/2024 am IST
|
5-day change
|
1st Jan Change
|
192.9
CNY
|
-2.50%
|
|
+3.13%
|
-40.71%
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,456
|
36,049
|
33,284
|
33,157
|
19,654
|
-
|
-
|
Enterprise Value (EV)
1 |
12,456
|
36,049
|
31,900
|
33,258
|
17,059
|
16,305
|
19,654
|
P/E ratio
|
45.5
x
|
74.5
x
|
52
x
|
56.6
x
|
22.9
x
|
17.3
x
|
16
x
|
Yield
|
-
|
0.44%
|
0.63%
|
0.61%
|
1.34%
|
1.61%
|
2.11%
|
Capitalization / Revenue
|
15.9
x
|
30.4
x
|
21.5
x
|
17.8
x
|
8.43
x
|
6.56
x
|
5.94
x
|
EV / Revenue
|
15.9
x
|
30.4
x
|
20.6
x
|
17.8
x
|
7.32
x
|
5.44
x
|
5.94
x
|
EV / EBITDA
|
44.9
x
|
61.7
x
|
43.1
x
|
45.4
x
|
14.6
x
|
12.2
x
|
12.6
x
|
EV / FCF
|
-
|
640
x
|
-79.6
x
|
-22
x
|
27.9
x
|
22.6
x
|
20.6
x
|
FCF Yield
|
-
|
0.16%
|
-1.26%
|
-4.54%
|
3.59%
|
4.43%
|
4.86%
|
Price to Book
|
4.73
x
|
11.8
x
|
9.19
x
|
8.14
x
|
3.84
x
|
3.2
x
|
2.95
x
|
Nbr of stocks (in thousands)
|
1,01,567
|
1,01,567
|
1,01,768
|
1,01,941
|
1,01,906
|
-
|
-
|
Reference price
2 |
122.6
|
354.9
|
327.1
|
325.3
|
192.9
|
192.9
|
192.9
|
Announcement Date
|
23/02/21
|
24/02/22
|
23/02/23
|
19/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
784.1
|
1,187
|
1,549
|
1,864
|
2,331
|
2,997
|
3,310
|
EBITDA
1 |
277.7
|
584
|
739.9
|
732.7
|
1,164
|
1,331
|
1,561
|
EBIT
1 |
246.4
|
549.9
|
708.7
|
683.6
|
892.2
|
1,205
|
1,372
|
Operating Margin
|
31.42%
|
46.31%
|
45.75%
|
36.68%
|
38.28%
|
40.22%
|
41.44%
|
Earnings before Tax (EBT)
1 |
254.6
|
559.9
|
708.7
|
685
|
965.1
|
1,262
|
1,377
|
Net income
1 |
225.3
|
484
|
641.3
|
607.5
|
860
|
1,129
|
1,228
|
Net margin
|
28.73%
|
40.77%
|
41.4%
|
32.59%
|
36.89%
|
37.68%
|
37.11%
|
EPS
2 |
2.693
|
4.764
|
6.293
|
5.750
|
8.440
|
11.12
|
12.04
|
Free Cash Flow
1 |
-
|
56.36
|
-400.7
|
-1,510
|
612
|
723
|
956
|
FCF margin
|
-
|
4.75%
|
-25.87%
|
-81.04%
|
26.25%
|
24.13%
|
28.88%
|
FCF Conversion (EBITDA)
|
-
|
9.65%
|
-
|
-
|
52.55%
|
54.3%
|
61.24%
|
FCF Conversion (Net income)
|
-
|
11.64%
|
-
|
-
|
71.16%
|
64.03%
|
77.82%
|
Dividend per Share
2 |
-
|
1.571
|
2.071
|
2.000
|
2.582
|
3.112
|
4.070
|
Announcement Date
|
23/02/21
|
24/02/22
|
23/02/23
|
19/04/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 S1
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
---|
Net sales
1 |
-
|
-
|
363.6
|
631.7
|
-
|
445.2
|
828.5
|
-
|
-
|
-
|
-
|
466.9
|
528
|
-
|
-
|
-
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
|
-
|
-
|
191
|
316.2
|
-
|
146.8
|
413.3
|
-
|
-
|
-
|
-
|
204.1
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
52.53%
|
50.05%
|
-
|
32.98%
|
49.89%
|
-
|
-
|
-
|
-
|
43.72%
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
193.8
|
324.4
|
-
|
146.7
|
413.2
|
-
|
216.2
|
364.9
|
-
|
204.5
|
-
|
-
|
-
|
-
|
Net income
1 |
209.8
|
116.1
|
158.2
|
274.3
|
276.4
|
133.3
|
364.9
|
-
|
187.9
|
324.6
|
-
|
174.6
|
164
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
43.51%
|
43.42%
|
-
|
29.95%
|
44.04%
|
-
|
-
|
-
|
-
|
37.39%
|
31.06%
|
-
|
-
|
-
|
EPS
2 |
2.064
|
1.143
|
1.557
|
2.700
|
2.721
|
1.293
|
3.571
|
1.620
|
1.560
|
-
|
1.060
|
1.500
|
2.870
|
1.990
|
1.640
|
2.650
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
04/08/21
|
21/10/21
|
24/02/22
|
24/02/22
|
28/08/22
|
23/02/23
|
23/02/23
|
26/04/23
|
28/08/23
|
28/08/23
|
14/10/23
|
19/04/24
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
101
|
-
|
-
|
-
|
Net Cash position
1 |
-
|
-
|
1,384
|
-
|
2,595
|
3,348
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
0.1375
x
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
56.4
|
-401
|
-1,510
|
612
|
723
|
956
|
ROE (net income / shareholders' equity)
|
21.8%
|
17%
|
19.3%
|
15%
|
17.6%
|
18.8%
|
18.6%
|
ROA (Net income/ Total Assets)
|
-
|
15%
|
13.7%
|
8.3%
|
11.4%
|
12.8%
|
-
|
Assets
1 |
-
|
3,228
|
4,678
|
7,315
|
7,522
|
8,845
|
-
|
Book Value Per Share
2 |
25.90
|
30.00
|
35.60
|
40.00
|
50.30
|
60.30
|
65.50
|
Cash Flow per Share
2 |
2.580
|
2.440
|
3.110
|
3.340
|
6.550
|
14.60
|
8.230
|
Capex
1 |
-
|
192
|
717
|
1,851
|
615
|
483
|
414
|
Capex / Sales
|
-
|
16.14%
|
46.31%
|
99.3%
|
26.39%
|
16.13%
|
12.51%
|
Announcement Date
|
23/02/21
|
24/02/22
|
23/02/23
|
19/04/24
|
-
|
-
|
-
|
Last Close Price
192.9
CNY Average target price
304.3
CNY Spread / Average Target +57.77% Consensus |
1st Jan change
|
Capi.
|
---|
| -40.71% | 2.71B | | -5.77% | 14.68B | | -12.92% | 2.44B | | -8.78% | 1.51B | | -.--% | 1.12B | | +40.66% | 518M | | +11.68% | 239M | | +1.67% | 183M | | -.--% | 168M | | -34.20% | 163M |
Medical Imaging Systems
|